The regulatory subunit of maturation-promoting factor (MPF) is called _______________

The regulatory subunit of maturation-promoting factor (MPF) is called _______________ Correct Answer cyclin

The regulatory subunit of maturation-promoting factor (MPF) is called cyclin. The concentration of this regulatory protein changes in a predictable pattern. When the cyclin concentration is low, the enzyme is inactive.

Related Questions

What happens when the gp130 subunit and the leukemia inhibitory factor receptor β-subunit is combined with a ciliary neurotrophic factor’s receptor subunit?
For non-compliance with regulatory requirements, which of the following Central government regulatory body has cancelled the authorization certificates of Muthoot Vehicle and Asset Finance Ltd and Eko India Financial Services Private Ltd for non-compliance with regulatory requirements in January 2022?
In the question below, are given a statement followed by three courses of actions numbered I, II and III. On the basis of the information given, you have to assume everything in the statement to be true, and then decide which of the suggested courses of action logically follow(s) for pursuing. Statement: India’s pharmaceutical sector is now popping out from a shell and making a remarkable recovery. Actually, it has been facing several regulatory challenges in the forms of a recast of foreign direct investment (FDI) policy, pricing policy in the US generics market, patent protection, regulatory approvals and compulsory licensing. Also limited new product launches in the generics space, GST introduction and higher costs associated with regulatory compliance have hurt the sector. Courses of action: I. The government has been engrossed more in policy making and taking resilient decisions for the concerns of the pharma industry. Recently, the government proposed to introduce a new price index for pharmaceutical products, which would serve as a benchmark for determining prices of all medicines sold in the country. II. Meanwhile, pharma companies’ constant investments in R&D have enabled them to develop a basket of robust products for markets across the world. In international markets, pricing pressure on generics sold in the US has eased and this is likely to support the sector. III. Domestic pharma sales grew to Rs. 10,583 crore in May 2018 from Rs. 9,549 crore in the same month last year. The recent clearance by the US Food and Drug Administration to Sun Pharma’s manufacturing plant at Halol in Gujarat brings to an end a two-year import ban it had imposed on the company over quality issues. This is likely to increase sales for the company.
Which regulatory body has reconstituted its advisory committee on leveraging regulatory and technology solutions (ALeRTS) in April 2022?